Michael Szarek

31PUBLICATIONS
118CO-AUTHORS
Exercise physiologyCardiology (incl. cardiovascular diseases)Social epidemiologyMedical biochemistry - lipidsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jan 16, 2026
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT.

Michael Szarek, Deepak L Bhatt, Michael Miller

|Dec 01, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome.

Sotirios Tsimikas, Michael Szarek, Christa M Cobbaert

|Oct 23, 2025
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.

Shea Hogan, Michael Szarek, E Sebastian Debus

|Sep 25, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy.

Esther Reijnders, Patrick M Bossuyt, J Wouter Jukema

Pageof 6